Skip to main content

2021-program

Program

For information, please contact Nicole Levesque (levesque@hsph.harvard.edu, 617-432-4902)

Register Here!

Monday, May 17, 2021
Virtual Meeting via Zoom and all times below are EDT

8:30 – 8:45Welcome & Introduction
8:45 – 9:00Yasmine Belkaid, NIH/NIAID
Opening Remarks
9:00 – 10:00Maria Gloria Dominguez-Bello, Rutgers University
“The human microbiome in a disruptive era”
10:00 – 10:30Amy Willis, University of Washington
“Estimating microbial abundances from high-throughput sequencing”
10:30 – 10:45Caroline Young, University of Leeds
“Screening potential of the CRC-associated microbiome”
10:45 – 11:00Marissa Bivins, University of North Carolina, Chapel Hill
“Discovery of the Gut Microbial Enzymes that Drive the Dose-Limiting Toxicity of the Immunosuppressant Mycophenolate Mofetil”
11:00 – 11:15Break
11:15 – 11:45Liz Johnson, Cornell University
“Dietary lipids as modulators of microbiome function”
11:45 – 12:15Greg Caporaso, Northern Arizona University
“Accessible and reproducible microbiome multi-omics bioinformatics with QIIME 2”
12:15 – 1:30Lunch Break
1:30 – 2:00Dong Daniel Wang, Harvard Medical School, Brigham & Women’s Hospital
“The Gut Microbiome Modifies the Associations between Diet and Cardiometabolic Disease Risk”
2:00 – 2:15Apollo Stacy, NIH/NIGMS
“Infection trains the host for microbiota-enhanced resistance to pathogens”
2:15 – 2:30Amrisha Bhosle, Broad Institute & Harvard T.H. Chan School of Public Health
“Prioritization and Annotation of Novel Bioactive Small Molecules from the Microbiome”
2:30 – 2:45Break
2:45 – 3:15Elaine Hsiao, University of California, Los Angeles
“Interactions between the microbiome and nervous system during early neurodevelopment”
3:15 – 4:15Peter Turnbaugh, University of California, San Francisco
“The tiny pharmacists within: how the microbiome impacts the treatment of chronic and infectious diseases”
4:15 – 4:30Closing Remarks
Poster Reception available online all day here